Literature DB >> 25126855

Human parechovirus infection in neonatal intensive care.

Jonathan Davis1, Derek Fairley, Sharon Christie, Peter Coyle, Richard Tubman, Michael D Shields.   

Abstract

BACKGROUND: Approximately 5-6% of all infective episodes in neonatal intensive care unit (NICU) are of viral origin. Previous studies suggest that human parechovirus (HPeV) infection presents most commonly in term infants, as a sepsis-like syndrome in which meningoencephalitis is prominent. Our aim was to study the infection rate and associated features of HPeV.
METHODS: Blood samples were taken from NICU babies older than 48 hours, who were being investigated for late onset sepsis. Clinical and laboratory data were collected at the time of the suspected sepsis episode. Samples were tested using universal primers and probe directed at the 5'-untranslated region of the HPeV genome by reverse transcriptase polymerase chain reaction (RT-PCR). Results were confirmed by electrophoresis and DNA sequencing.
RESULTS: HPeV was detected in 11 of 84 samples (13%). These infants had a mean [interquartile range (IQR)] gestational age of 28.9 (26.9-30.6) weeks and mean birth weight of 1.26 (SD = 0.72) kg. The median day of presentation was 16 (IQR: 11-27). These characteristics were similar to the infants without positive viral detection. Six infants presented with respiratory signs. One infant presented with signs of meningitis. Six of the 11 episodes of HPeV infection occurred during the winter months (December to February). No HPeV positive infants had abnormal findings on their 28-day cranial ultrasound examination.
CONCLUSIONS: We found an HPeV infection rate of 13% in infants being tested for late onset sepsis. HPeV should be considered as a possible cause of sepsis-like symptoms in preterm infants.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25126855     DOI: 10.1097/INF.0000000000000510

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Severe Parechovirus 3 Infections in Young Infants-Kansas and Missouri, 2014.

Authors:  Claire M Midgley; Mary Anne Jackson; Rangaraj Selvarangan; Patrick Franklin; Elizabeth L Holzschuh; Jennifer Lloyd; Joseph Scaletta; Anne Straily; Sheri Tubach; Ashley Willingham; W Allan Nix; M Steven Oberste; Christopher J Harrison; Charles Hunt; George Turabelidze; Susan I Gerber; John T Watson
Journal:  J Pediatric Infect Dis Soc       Date:  2018-05-15       Impact factor: 3.164

2.  Nosocomial Outbreak of Parechovirus 3 Infection among Newborns, Austria, 2014.

Authors:  Volker Strenger; Sabine Diedrich; Sindy Boettcher; Susanne Richter; Peter Maritschnegg; Dietmar Gangl; Simone Fuchs; Gernot Grangl; Bernhard Resch; Berndt Urlesberger
Journal:  Emerg Infect Dis       Date:  2016-09       Impact factor: 6.883

Review 3.  Prevention and treatment of neonatal nosocomial infections.

Authors:  Jayashree Ramasethu
Journal:  Matern Health Neonatol Perinatol       Date:  2017-02-13

4.  Human parechovirus: sepsis-like illness with pulmonary infection.

Authors:  Luíne Rosele Renaud Vidal; Bárbara Cavalli; Sérgio Monteiro de Almeida; Sônia Mara Raboni; Meri Bordignon Nogueira
Journal:  Braz J Infect Dis       Date:  2017-07-07       Impact factor: 1.949

5.  Cerebral imaging and neurodevelopmental outcome after entero- and human parechovirus sepsis in young infants.

Authors:  Eveline P de Jong; Herma C Holscher; Sylke J Steggerda; Jeanine M M Van Klink; Erika P M van Elzakker; Enrico Lopriore; Frans J Walther; Frank Brus
Journal:  Eur J Pediatr       Date:  2017-09-10       Impact factor: 3.183

6.  Viral Infections in Neonates with Suspected Late-Onset Bacterial Sepsis-A Prospective Cohort Study.

Authors:  André Kidszun; Lena Klein; Julia Winter; Isabella Schmeh; Britta Gröndahl; Stephan Gehring; Markus Knuf; Kerstin Weise; Eva Mildenberger
Journal:  Am J Perinatol       Date:  2016-05-16       Impact factor: 1.862

Review 7.  Review of the clinical significance of respiratory virus infections in newborn infants.

Authors:  Raakel Luoto; Tuomas Jartti; Olli Ruuskanen; Matti Waris; Liisa Lehtonen; Terho Heikkinen
Journal:  Acta Paediatr       Date:  2016-07-31       Impact factor: 2.299

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.